share_log

Silo Pharma Shares Are Trading Lower After the Company Completed a Pre-investigational New Drug Meeting With the FDA for SPOC-15, an Intranasal Prophylactic Treatment for PTST and Stress-induced Anxiety Disorder.

Benzinga ·  Sep 10 22:52
Silo Pharma Shares Are Trading Lower After the Company Completed a Pre-investigational New Drug Meeting With the FDA for SPOC-15, an Intranasal Prophylactic Treatment for PTST and Stress-induced Anxiety Disorder.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment